歙县1036例孕中期妇女产前筛查结果分析  

Prenatal screening results of 1036 mid-pregnancy women in Shexian County

作　　者：潘野清 张健安 程莺莺 舒贝敏 吴超 PAN Ye-qing;ZHANG Jian-an;CHENG Ying-ying;SHU Bei-min;WU Chao(Shexian County maternal and child health care hospital,Anhui 245200,China)

机构地区：[1]歙县妇幼保健院,安徽245200

出　　处：《安徽预防医学杂志》2022年第2期117-119,共3页Anhui Journal of Preventive Medicine

摘　　要：目的通过分析歙县1036名孕中期妊娠妇女产筛资料,了解胎儿发病风险,为预防出生缺陷提供科学依据。方法采用化学发光免疫分析法检测孕中期妊娠妇女血清β-人绒毛膜促性腺激素(β-HCG)、甲胎蛋白(AFP)和游离雌三醇(uE3)水平,结合孕妇年龄、体重、孕周等数据进行分析,计算胎儿发病风险率。结果筛查的1036名孕妇中,高风险61例,占5.8%;临界风险组43例,占4.2%;低风险932例,占90.0%。随访1010名孕妇的妊娠结局,治疗性引产9例,不同风险组孕妇治疗性引产比例差异有统计学意义(χ^(2)=9.984,P=0.006)。孕妇合并妊娠期高血压疾病32例,其中临界风险组和高风险组妊娠期高血压的检出率高于低风险组(χ^(2)=5.432,P=0.045)。结论孕中期血清学筛查对预防出生缺陷具有重要作用。Objective The screening information of 1036 women in the second trimester of pregnancy in Shexian County were analyzed to understand the risk of fetal morbidity and to provide scientific basis for the prevention of birth defects.Methods Serumβ-human chorionic gonadotropin(β-HCG),alpha fetoprotein(AFP)and free estriol(uE3)levels in mid-pregnancy women were detected by chemiluminescence immunoassay.These indicators calculated the risk rate of fetal morbidity by combining maternal age,weight,and gestational weeks.Results Of the 1036 pregnant women screened,there were 61 cases(5.8%)in the high-risk group,43 cases(4.2%)in the borderline risk group,and 932 cases(90.0%)in the low-risk group.The pregnancy outcomes of 1010 pregnant women were followed up,with 9 cases of therapeutic induced of labor.The differences of the therapeutic induced labor rates in different risk groups were statistically significance(χ^(2)=9.984,P=0.006).There were 32 cases of combined gestational hypertension in pregnant women.Notably,the detection rate of hypertension in pregnancy was higher in the borderline risk and high risk groups than in the low risk group(χ^(2)=5.432,P=0.045).Conclusion Serological screening in the second trimester of pregnancy has significant effect on the prevention of birth defects.

关 键 词：孕中期 产前筛查 出生缺陷 风险评估 妇幼保健 优生优育 

分 类 号：R173[医药卫生—妇幼卫生保健]